Bill > S2756

This bill, called the "Affordable Inhalers and Nebulizers Act of 2025," aims to reduce the cost of prescription inhalers for patients with breathing disorders like asthma and chronic obstructive pulmonary disease (COPD). The bill introduces comprehensive changes across multiple healthcare systems, requiring private insurance plans, Medicare Part B and Part D, and other health coverage to limit cost-sharing for specified inhaler products to no more than $15 per 30-day supply. These specified inhaler products include various types of inhalers, such as metered dose inhalers, dry powder inhalers, inhalation solutions, bronchodilators, and corticosteroids, as well as related administration equipment like masks, spacers, and nebulizers. Additionally, the bill establishes a new payment program for uninsured individuals, allowing healthcare providers to submit claims to the government for providing inhaler products to patients who do not have health insurance, with the provider agreeing not to charge the patient more than $15 for a month's supply. The changes will take effect for plan years beginning on or after January 1, 2026, with the goal of making essential breathing medications more affordable and accessible to patients.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/2756/all-info